Elsevier

Brain Research

Volume 556, Issue 2, 16 August 1991, Pages 311-316
Brain Research

Increase of sodium channels in demyelinated lesions of multiple sclerosis

https://doi.org/10.1016/0006-8993(91)90321-LGet rights and content

Abstract

Redistribution of sodium channels along demyelinated pathways in multiple sclerosis (MS) could be an important event in restoring conduction prior to other reparative mechanisms such as remyelination. Sodium channels in human multiple sclerosis lesions were identified by quantitative light microscopic autoradiography using tritiated saxitoxin (STX), a highly specific sodium channel ligand. Demyelinated areas in various central nervous system regions containing denuded but vital axons exhibited a high increase of STX-binding sites by up to a factor of 4 as compared to normal human white matter. This important finding could be explain aspects of fast clinical remissions and ‘silent’ MS lesions on functional and morphological properties. Demyelinated axons may functionally reorganize their membranes and adapt properties similar to those of slow conducting unmyelinated nerve fibres which have a higher amount and a more diffuse distribution of STX binding sites. This report is the first description of an altered distribution of voltage-sensitive sodium channels in human multiple sclerosis lesions.

References (27)

  • BevanS. et al.

    The presence of voltage-gated sodium, potassium and chloride channels in rat cultured astrocytes

  • BevanS. et al.

    Voltage-gated ion channels in rat cultured astrocytes

  • BostockH. et al.

    Continuous conduction in demyelinated mammalian nerve fibres

    Nature

    (1976)
  • Cited by (114)

    • Acquired channelopathies as contributors to development and progression of multiple sclerosis

      2014, Experimental Neurology
      Citation Excerpt :

      Interestingly, EAE severity in this mouse model is reduced and associated with decreased neuronal degeneration and axonal loss (O'Malley et al., 2009). From a conceptual point of view, it is widely believed that the diffuse expression of Nav channels after demyelination helps to keep up normal conduction of action potentials (Moll et al., 1991). While this is highly beneficial in phases of acute injury, the spreading of Nav channels might as well be counterproductive by contributing to excitotoxicity during chronic disease.

    • Molecular mechanisms linking neuroinflammation and neurodegeneration in MS

      2014, Experimental Neurology
      Citation Excerpt :

      Demyelination of axons disturbs the salutatory conduction of nerves. Sodium channels that are primarily expressed at the nodes of Ranvier (and nerve terminals) are upregulated in formerly myelinated axonal sections to restore nerve conduction in MS patients (Moll et al., 1991; Waxman, 2006). This redistribution of sodium channels causes an increased energy (ATP) demand to reduce increasing sodium levels via the Na+/K+ ATPase (Craner et al., 2004; Dutta et al., 2006).

    • Demyelination in multiple sclerosis

      2014, Handbook of Clinical Neurology
      Citation Excerpt :

      Paranodal and juxtaparanodal axonal proteins are also profoundly modified. A redistribution of Nav channels along the naked axon has been reported in experimental models of demyelination and in MS lesions both by autoradiography and by immunohistochemistry (Moll et al., 1991; Noebels et al., 1991; Craner et al., 2004a, b; Coman et al., 2006). It remains unknown whether this change is due to a Nav channel synthesis or to a redistribution of Nav channels from nearby nodes into the demyelinated (previously internodal) membrane.

    • Clinical neurophysiology of multiple sclerosis

      2014, Handbook of Clinical Neurology
      Citation Excerpt :

      Moreover, abnormalities on multimodal EPs may be predictive of future development of disability (Kallmann et al., 2006; Leocani et al., 2006; Jung et al., 2008), especially in the early stages of the disease (Kallmann et al., 2006; Jung et al., 2008), suggesting that EPs could be useful in the identification of patients with initial, subclinical involvement of eloquent pathways, which are important in determining the development of disability. After unilateral optic neuritis, VEPs detected improving nervous conduction over more than 3 years (Niklas et al., 2009) and 5 years (Brusa et al., 2001), despite little recovery in visual function, possibly related to remyelination (Brück et al., 2003; Patrikios et al., 2006; Patani et al., 2007) or ion channel reorganization in the demyelinated region (Waxman, 1978, 2002; Moll et al., 1991). Subtle worsening of conduction in the fellow asymptomatic eye has been suggested to indicate an insidious demyelinating process which, although accompanied by worsening of contrast sensitivity, would have been undetected by clinical examination alone (Brusa et al., 2001).

    • Sodium imaging as a marker of tissue injury in patients with multiple sclerosis

      2013, Multiple Sclerosis and Related Disorders
      Citation Excerpt :

      While the expression of some Na channel isoforms may have an adaptive role restoring conduction, other isoforms may have a maladaptive role contributing to axonal degeneration (Smith and Lassmann, 2002). Immunocytochemical studies using panspecific Na channel antibodies subsequently confirmed the appearance of increased numbers of Na channels in experimentally demyelinated axons and in demyelinated lesions from MS patients (England et al., 1991; Moll et al., 1991). It has been hypothesized that the molecular mechanisms of axonal/neuronal injury in inflammatory demyelinating diseases shares a final common pathway with those in hypoxia (Stys, 2004): under both pathophysiological conditions, a mismatch of the cellular demand and the production of energy can occur with subsequent depletion of adenosine tri-phosphate (ATP).

    View all citing articles on Scopus

    We wish to thank Prof. M. Mumenthaler, Bern, and Dr. J. Kesselring, Valens. This work was generously supported by a grant from The Swiss Multiple Sclerosis Society.

    **

    Permanent address: Institute of Pathology, University of Zürich, 8901 Zürich, Switzerland.

    View full text